Seroquel ® in Patients With Bipolar Disorder in Remission With Signs of Impaired Impulse Control
Status:
Recruiting
Trial end date:
2021-12-01
Target enrollment:
Participant gender:
Summary
In this study, the task was to evaluate the effectiveness of prescribing small doses of
quetiapine (25-75 mg) for bipolar patients in remission in order to relieve symptoms of
impulsivity.
Phase:
N/A
Details
Lead Sponsor:
Federal Stare Budgetary Scientific Institution, Mental Health Research Center
Collaborators:
Federal State Budgetary Institution V.M. Bekhterev National Research Medical Center for Psychiatry and Neurology, Saint-Petersburg, Russia Kazan State Medical University